White matter hyperintensities, usually abbreviated WMH, are far more than a radiological curiosity. They represent areas where the deep and periventricular white matter—the cabling that connects distant brain regions—has been injured by the gradual failure of the brain’s smallest blood vessels. On fluid-attenuated inversion recovery, or FLAIR, MRI sequences, these damaged zones appear as hyperintense signals because the tissue has accumulated excess fluid, gliosis, and loss of myelin. In the elderly, WMH are nearly ubiquitous: in this study, 325 of 428 participants, or 75.9 percent, already had them at baseline. Clinically, they are linked to gait disturbance, cognitive decline, stroke risk, and vascular dementia, yet they often progress for years without any obvious symptoms, which is why researchers are so eager to find cheap, accessible indicators of who is most at risk.

The research team, led by Zhaoxia Liu and colleagues at the Huai’an Hospital of Traditional Chinese Medicine in China, enrolled consecutively hospitalized patients aged 60 or above who underwent baseline cranial MRI. WMH severity was graded using the Fazekas scale, a widely used three-point radiological system that separately scores periventricular hyperintensities and deep white matter hyperintensities and then combines them into an overall grade. At the same time, the investigators measured three peripheral blood inflammatory markers: the absolute neutrophil count, or NC; the neutrophil-to-lymphocyte ratio, or NLR; and the white blood cell-to-lymphocyte ratio, or WLR. All three are derived from the standard complete blood count, meaning they require no additional blood draw, no specialized assay, and essentially no added cost.

The technical logic behind these markers is worth unpacking. Neutrophils are the front-line soldiers of the innate immune system, rising rapidly during acute infection and systemic inflammation. Lymphocytes, by contrast, mediate adaptive immunity and tend to fall under chronic inflammatory stress. The NLR therefore captures the balance between pro-inflammatory activation and immune regulation in a single ratio, and it has emerged in recent years as a robust composite index of systemic inflammation in cardiovascular and cerebrovascular disease. The WLR extends the same principle to the entire white cell population divided by the lymphocyte count. Because both ratios are readily calculable from any standard count, they have attracted attention as potential risk stratification tools in settings where advanced biomarkers are unavailable.

Using multivariable logistic regression adjusted for confounders, the team found that higher NC, NLR, and WLR were each independently associated with the presence of WMH, with all associations reaching statistical significance at P less than 0.05. The picture became more nuanced when severity was considered. NLR and WLR were associated with both moderate and severe WMH, suggesting these ratios track disease across its stages, while NC was associated only with severe WMH, positioning the raw neutrophil count as a marker of advanced disease rather than early change.

Dose-response analysis strengthened the case. When participants were divided into quartiles of each marker, the highest quartile, Q4, was associated with severe WMH after Benjamini-Hochberg false discovery rate correction, a statistical method that guards against spurious findings when many comparisons are made. The adjusted odds ratios were 2.033 for NC, 1.503 for NLR, and 1.581 for WLR. In other words, older adults whose inflammatory markers fell in the top quarter of the distribution carried roughly one-and-a-half to two times the odds of severe white matter damage compared with those in the lowest quartile, even after accounting for other clinical variables.

The most striking results came from the longitudinal arm of the study. Among 338 patients with follow-up imaging, the investigators assessed radiological progression over three years, defined as an increase of at least one point on the Fazekas score. Baseline Q4 levels of all three markers strongly predicted this future progression: the odds ratios were 4.035 for NC, 5.184 for NLR, and 4.076 for WLR. A single routine blood count taken at baseline, in other words, carried roughly four- to five-fold odds of identifying who would show measurable worsening of white matter damage on MRI three years later. This predictive power for future progression is what elevates the findings beyond a simple cross-sectional correlation.

The markers also delivered a modest but measurable boost to predictive performance. Adding them to a basic clinical model improved the area under the curve, or AUC, from 0.753 to a range of 0.757 to 0.762. The improvement is small in absolute terms, and the authors are careful not to oversell it, but it demonstrates that inflammatory profiling adds incremental information to established clinical variables rather than duplicating them. Notably, the WLR, despite being the simplest of the three indices to calculate, showed predictive value comparable to the more widely studied NLR, which may make it the more practical candidate for everyday screening.

What might be happening biologically? Systemic inflammation is increasingly implicated in cerebral small vessel disease, the underlying pathology of WMH. Elevated circulating neutrophils can damage the endothelium, the delicate single-cell lining of blood vessels, through oxidative burst and protease release, promoting the blood-brain barrier dysfunction and endothelial injury that characterize small vessel disease. Chronic inflammation also favors the atherosclerotic and arteriosclerotic changes that stiffen the brain’s perforating arteries, starving the deep white matter of adequate perfusion. The lymphocyte component of the ratios may reflect the depletion of immune regulation that accompanies chronic inflammatory aging, sometimes called inflammaging. The new study does not prove these mechanisms directly, but its longitudinal design is consistent with the hypothesis that systemic inflammation is not merely a bystander in white matter damage.

The authors are explicit about the limits of their work. The cohort consisted of hospitalized patients rather than healthy community dwellers, which may limit generalizability, and the markers were measured at baseline rather than repeatedly over time, so fluctuations in inflammatory status could not be captured. The AUC improvement was modest, and the study cannot establish causation. Before these markers can be integrated into cerebral small vessel disease risk stratification frameworks, the team calls for external validation in community-based cohorts with repeated inflammatory profiling. Still, the appeal of the approach is hard to deny: if a standard complete blood count, already ordered millions of times a day in hospitals worldwide, can help flag older adults at risk of progressive white matter damage, it could open a low-cost route to earlier monitoring, more aggressive vascular risk management, and closer MRI surveillance for the patients who need it most.

Subject of Research: Neuroscience

Article Title: Association of peripheral blood inflammatory markers with white matter hyperintensities in the elderly

Article References: Liu, Z., Shi, K., Shu, Z., Zhang, K., Yu, Q., & Wang, B. (2026). Association of peripheral blood inflammatory markers with white matter hyperintensities in the elderly. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08474-8

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08474-8

Keywords: white matter hyperintensities, inflammation, neutrophil-to-lymphocyte ratio, cerebral small vessel disease, brain MRI, aging, biomarkers, BMC Geriatrics, Association, peripheral, blood, inflammatory